NGM BIOPHARMACEUTICALS INC - COM (NGM)

CUSIP: 62921N105

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM
Total 13F shares
29,843,007
Share change
+2,147,597
Total reported value
$627,606,289
Put/Call ratio
33%
Price per share
$21.02
Number of holders
117
Value change
+$49,369,343
Number of buys
66
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 62921N105?
CUSIP 62921N105 identifies NGM - NGM BIOPHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NGM BIOPHARMACEUTICALS INC - COM (NGM) as of Q3 2021

As of 30 Sep 2021, NGM BIOPHARMACEUTICALS INC - COM (NGM) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,843,007 shares. The largest 10 holders included RHO CAPITAL PARTNERS INC, Redmile Group, LLC, BlackRock Inc., StepStone Group LP, VANGUARD GROUP INC, Point72 Asset Management, L.P., FMR LLC, Ponoi II Management, LLC, Ponoi Management, LLC, and BVF INC/IL. This page lists 117 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.